ERBB2 and breast carcinoma: The study on breast cancer treatment using carbon nanotubes coated with anti-Her2+ antibody was conducted by Marches et al. The research set out to determine the efficiency and selectivity of the NIR-mediated thermal ablation of Her2+ human breast carcinoma cancer cells.